Correlation Between Tscan Therapeutics and Alvarium Tiedemann
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Alvarium Tiedemann at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Alvarium Tiedemann into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Alvarium Tiedemann Holdings, you can compare the effects of market volatilities on Tscan Therapeutics and Alvarium Tiedemann and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Alvarium Tiedemann. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Alvarium Tiedemann.
Diversification Opportunities for Tscan Therapeutics and Alvarium Tiedemann
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tscan and Alvarium is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Alvarium Tiedemann Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvarium Tiedemann and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Alvarium Tiedemann. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvarium Tiedemann has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Alvarium Tiedemann go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Alvarium Tiedemann
Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Alvarium Tiedemann. In addition to that, Tscan Therapeutics is 1.07 times more volatile than Alvarium Tiedemann Holdings. It trades about -0.25 of its total potential returns per unit of risk. Alvarium Tiedemann Holdings is currently generating about -0.16 per unit of volatility. If you would invest 392.00 in Alvarium Tiedemann Holdings on December 1, 2024 and sell it today you would lose (46.00) from holding Alvarium Tiedemann Holdings or give up 11.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Alvarium Tiedemann Holdings
Performance |
| Timeline |
| Tscan Therapeutics |
| Alvarium Tiedemann |
Tscan Therapeutics and Alvarium Tiedemann Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Alvarium Tiedemann
The main advantage of trading using opposite Tscan Therapeutics and Alvarium Tiedemann positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Alvarium Tiedemann can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvarium Tiedemann will offset losses from the drop in Alvarium Tiedemann's long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| Alvarium Tiedemann vs. Apogee Therapeutics, Common | Alvarium Tiedemann vs. Albertsons Companies | Alvarium Tiedemann vs. Cedar Realty Trust | Alvarium Tiedemann vs. Spyre Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |